health
February 6, 2026
Trump puts seniors first by making drugs affordable again
For decades, the United States has led the world in developing groundbreaking medications that allow patients to live longer and healthier lives. Despite these contributions, American families pay substantially higher prices for these breakthroughs than patients in any other country. The Trump administration just announced a major new policy to ensure seniors with chronic conditions can access the medications they need at their lowest global price.
TL;DR
- A new Medicare pilot program will allow seniors to purchase brand-name drugs at prices comparable to those in other wealthy countries.
- This initiative seeks to address the high cost of prescription drugs in the U.S., where Americans pay significantly more than patients in other developed nations.
- High drug prices have led to medication nonadherence among Americans, resulting in worsened health and premature deaths.
- The program is expected to reduce out-of-pocket expenses for seniors by billions and save taxpayers additional funds.
- By tying U.S. prices to international rates, the policy aims to encourage other countries to pay more for drug development and potentially accelerate the creation of new medications.
Continue reading the original article